Dr. Mark Hoffman, M.D

NPI: 1639174048
Total Payments
$997.71
2024 Payments
$48.87
Companies
24
Transactions
64
Medicare Patients
1,246
Medicare Billing
$95,704

Payment Breakdown by Category

Food & Beverage$997.71 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $997.71 64 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $135.09 9 $0 (2017)
Insulet Corporation $125.48 9 $0 (2019)
Philips Electronics North America Corporation $77.78 4 $0 (2019)
Merck Sharp & Dohme Corporation $74.89 5 $0 (2019)
Lilly USA, LLC $62.21 4 $0 (2023)
Astellas Pharma US Inc $58.01 3 $0 (2017)
GlaxoSmithKline, LLC. $42.22 3 $0 (2024)
AbbVie Inc. $40.56 3 $0 (2021)
SANOFI-AVENTIS U.S. LLC $32.71 2 $0 (2019)
Inspire Medical Systems, Inc. $31.87 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $48.87 2 Inspire Medical Systems, Inc. ($31.87)
2023 $46.04 3 Lilly USA, LLC ($31.47)
2021 $54.19 4 AbbVie Inc. ($40.56)
2019 $222.98 15 Insulet Corporation ($55.05)
2018 $158.83 10 Eisai Inc. ($28.49)
2017 $466.80 30 Janssen Pharmaceuticals, Inc ($135.09)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 2 of 3

Date Company Product Nature Form Amount Type
11/15/2018 Senseonics, Incorporated Eversense (Device) Food and Beverage Cash or cash equivalent $12.00 General
Category: Endocrinology
11/02/2018 Philips Electronics North America Corporation Respiratoriy Care Undiv (Device) Food and Beverage Cash or cash equivalent $25.53 General
Category: Cardiology/Vascular Diseases
10/18/2018 Gilead Sciences, Inc. Food and Beverage In-kind items and services $13.34 General
08/23/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.40 General
Category: Cardiovascular and Metabolism
08/02/2018 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $12.10 General
Category: Insulin Pump
04/13/2018 Eisai Inc. Belviq (Drug) Food and Beverage Cash or cash equivalent $13.94 General
Category: Nutrition and Weight Loss
02/20/2018 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $11.76 General
Category: Insulin Pump
01/11/2018 Eisai Inc. Belviq (Drug) Food and Beverage Cash or cash equivalent $14.55 General
Category: Nutrition and Weight Loss
01/09/2018 Merck Sharp & Dohme Corporation JANUVIA (Drug), JANUMET, JANUMET XR Food and Beverage In-kind items and services $17.83 General
Category: ENDOCRINOLOGY
12/12/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $16.05 General
Category: Cardiovascular & Metabolism
10/24/2017 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $21.24 General
Category: Hypertriglyceridemia
10/10/2017 Orexigen Therapeutics, Inc. CONTRAVE (Drug) Food and Beverage In-kind items and services $15.12 General
Category: OBESITY
09/29/2017 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $17.49 General
Category: Insulin pump
09/28/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $0.69 General
Category: Cardiovascular & Metabolism
09/21/2017 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $17.85 General
Category: Insulin pump
09/05/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $19.31 General
Category: Cardiovascular & Metabolism
08/01/2017 Orexigen Therapeutics, Inc. CONTRAVE (Drug) Food and Beverage In-kind items and services $13.06 General
Category: OBESITY
06/27/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $12.67 General
Category: Cardiovascular & Metabolism
06/26/2017 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $11.23 General
Category: Insulin pump
06/20/2017 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $12.11 General
Category: DIABETES
05/31/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Cardiovascular & Metabolism
05/30/2017 SANOFI-AVENTIS U.S. LLC PRALUENT (Drug) Food and Beverage In-kind items and services $17.71 General
Category: CARDIOVASCULAR
05/24/2017 Merck Sharp & Dohme Corporation CUBICIN RF (Drug), ZERBAXA, SIVEXTRO Food and Beverage In-kind items and services $13.53 General
Category: INFECTIOUS DISEASE
05/23/2017 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $16.37 General
Category: DIABETES
05/17/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $12.79 General
Category: Opioid Induced Constipation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 223 246 $107,329 $22,193
2022 9 332 374 $53,988 $25,738
2021 8 372 418 $44,654 $23,867
2020 6 319 369 $35,936 $23,906
Total Patients
1,246
Total Services
1,407
Medicare Billing
$95,704
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 64 64 $36,526 $9,101 24.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 54 66 $37,304 $6,637 17.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 43 54 $21,584 $3,176 14.7%
90662 Influenza vaccine split virus, preservative free Office 2023 31 31 $8,680 $2,226 25.7%
G0008 Administration of influenza virus vaccine Office 2023 31 31 $3,235 $1,053 32.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 59 59 $14,517 $8,643 59.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 66 93 $21,717 $8,419 38.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 48 63 $11,086 $4,060 36.6%
90662 Influenza vaccine split virus, preservative free Office 2022 26 26 $2,406 $1,679 69.8%
G0444 Annual depression screening, 15 minutes Office 2022 60 60 $1,669 $1,274 76.3%
G0008 Administration of influenza virus vaccine Office 2022 27 27 $1,268 $911.70 71.9%
0064A Adm sarscov2 50mcg/0.25mlbst Office 2022 13 13 $650.00 $582.94 89.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 20 20 $675.67 $167.96 24.9%
91306 Sarscov2 vac 50mcg/0.25ml im Office 2022 13 13 $0.13 $0.13 100.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 72 95 $16,903 $7,737 45.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 73 73 $12,904 $7,107 55.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 48 65 $8,381 $3,866 46.1%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 40 41 $2,690 $2,661 98.9%
G0444 Annual depression screening, 15 minutes Office 2021 70 70 $1,802 $1,510 83.8%
G0008 Administration of influenza virus vaccine Office 2021 44 45 $1,676 $878.37 52.4%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 11 11 $297.71 $108.32 36.4%
91301 Sarscov2 vac 100mcg/0.5ml im Office 2021 14 18 $0.18 $0.18 100.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 66 66 $10,330 $8,587 83.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 100 138 $13,878 $7,917 57.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 43 48 $7,116 $3,595 50.5%

About Dr. Mark Hoffman, M.D

Dr. Mark Hoffman, M.D is a Internal Medicine healthcare provider based in Bayonne, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639174048.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Hoffman, M.D has received a total of $997.71 in payments from pharmaceutical and medical device companies, with $48.87 received in 2024. These payments were reported across 64 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($997.71).

As a Medicare-enrolled provider, Hoffman has provided services to 1,246 Medicare beneficiaries, totaling 1,407 services with total Medicare billing of $95,704. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Bayonne, NJ
  • Active Since 06/14/2005
  • Last Updated 09/20/2013
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1639174048

Products in Payments

  • Omnipod (Device) $125.48
  • INVOKANA (Drug) $69.05
  • JANUVIA (Drug) $61.36
  • Myrbetriq (Drug) $58.01
  • inCourage (Device) $52.25
  • INVOKAMET (Drug) $37.14
  • INSPIRE (Device) $31.87
  • HUMULIN (Drug) $30.74
  • XIFAXAN (Drug) $30.00
  • XARELTO (Drug) $28.90
  • Belviq (Drug) $28.49
  • JARDIANCE (Drug) $28.48
  • VRAYLAR (Drug) $28.24
  • CONTRAVE (Drug) $28.18
  • Respiratoriy Care Undiv (Device) $25.53
  • DISEASE STATE (Drug) $23.38
  • Vascepa (Drug) $21.24
  • AMRIX (Drug) $19.17
  • PRALUENT (Drug) $17.71
  • AREXVY (Drug) $17.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Bayonne